Amgen
A Principal Immunoengineer – Translational Human Immunology at Amgen leads translational protein design efforts to reduce or eliminate immunogenicity in large-molecule therapeutics. The role is based in British Columbia within the Large Molecule Discovery team and bridges experimental immunology and computational science to advance predictive in vitro biological systems and novel biologics.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Senior Research Investigator, Biologics Pharmacology, London
Isomorphic Labs
Quantitative Virology-Immunology - Postdoctoral Researcher
LLNL
All
Synolo Therapeutics
Senior Research Investigator, (Biologics Pharmacology), London
Isomorphic Labs
Computational Biologist Principal Research Scientist II
AbbVie
Senior Scientist, Translational Immunology
Parvus Therapeutics Inc